Notices

NOTICES

Product Warning: Guaiphenesin

Greyhound Racing NSW alerts participants about the prolonged excretion time of the prohibited substance, Guaiphenesin, found in the registered pharmaceutical medication, Robitussin.

There is no known withdrawal period for this product and the detection of Guaiphenesin in a race day sample from a greyhound would constitute a breach of the rules.

Trainers should avoid the administration of Robitussin in the week prior to racing.

For more information contact Bill Fanning, General Manager, Racing & Integrity on 8767 0500 or the GRNSW Stewards department.

Updated 14 Dec 2009

Inspection of Greyhounds After Naming

With the recent addition of Performance Trials Greyhound Racing NSW has made some amendments to the Inspection Times for the issuing of Weight Cards of Named Greyhounds prior to nominating for their first race start.

In addition to these times all greyhounds nominated to compete in a Performance Trial may have their Weight Card issued at the same meeting provided that they arrive on course no later than 30 mins prior to the opening time for Kennelling.

Named Greyhounds Inspection Times - click here to download

Inspection of Greyhounds After Naming Notice to Participants - click here to download

Updated 11 Dec 2009

Substance Alert: Pholcodine

Greyhound Racing NSW today issued a warning regarding the detection of the prohibited substance Pholcodine in race day samples. Pholcodine is commonly found in the pharmacy medicine Duro-Tuss Cough Liquid Expectorant.

Pholcodine is regarded as a prohibited substance under the Rules of Greyhound Racing and its detection in a sample would constitute an offence under Greyhound Australasia Rule 83.

Trainers should be mindful of the administration of any pharmaceutical medicines close to race day.

For more information contact General Manager Racing & Integrity, Bill Fanning 02 8767 0500.

Updated 13 Nov 2009

Warning: Use Of Hydrocortisone Sodium Succinate

Greyhound Racing NSW (GRNSW) alerts participants as from 1 November 2009, a new testing method will be introduced by Australian Racing Laboratories which will allow the direct detection of hydrocortisone hemisuccinate (arising from the use of hydrocortisone sodium succinate) in blood and urine samples.

This method does not require quantitative measurement under the Rules of Greyhound Racing.

Although no controlled administration trials have been conducted on greyhounds, the method detects recent use of the human prescription medicine Solu-Cortef, whose active ingredient is hydrocortisone sodium succinate, which should not be used close to racing.

Industry participants are therefore advised to avoid the use of hydrocortisone sodium succinate close to race day as the detection of this substance in a sample taken from a greyhound would constitute a breach of the Rules of Greyhound Racing.

For more information contact Bill Fanning, General Manager, Racing & Integrity on 8767 0500 or the GRNSW Stewards Department.

Updated 13 Oct 2009

Substance Alert: FIROCOXIB

Greyhound Racing NSW (GRNSW) today issued a warning to members of the sport about the prolonged excretion time of the prohibited substance Firocoxib, a non-steroidal anti-inflammatory drug (NSAID) commonly found in the registered veterinary product PREVICOX.

As a NSAID, Firocoxib is screened for in samples taken from greyhounds and the detection of this substance in a sample would constitute an offence under Greyhound Australasia Rule 83.

There is no known data supporting the withholding period of any preparation containing FIROCOXIB.

For more information contact General Manager Racing and Integrity Bill Fanning 02 8767 0530.

Updated 8 Sep 2009

Become a Member

Membership is free and will allow you to stay up to date with all the latest information about greyhound racing as well as access to most areas of the website.

Join